ClassID:

20558

A61K31/737 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate

Recent Application in this class:
#1
20260151426
2026-06-04

CHONDROITIN SULFATE POLYSACCHARIDE, AND SEMI-SYNTHETIC PREPARATION METHOD THEREFOR AND USE THEREOF

#2
20260144814
2026-05-28

METHOD FOR IMPROVING ATOPIC DERMATITIS BY USING A COMPOSITION COMPRISING LOW-MOLECULAR-WEIGHT FUCOIDAN

#3
20260130931
2026-05-14

ENERGY DRINK COMPOSITION

#4
20260124237
2026-05-07

CARTILAGE REGENERATION COMPOSITION

#5
20260097087
2026-04-09

RECOMBINANT FUSION POLYPEPTIDES FOR SECRETING SOLUBLE, HETEROLOGOUS CARGO

#6
20260078156
2026-03-19

TREATMENT OF NERVOUS SYSTEM INJURY AND NEURODEGENERATIVE DISORDERS AND RELATED CONDITIONS

#7
20260069628
2026-03-12

TREATMENT OF PSORIASIS, PSORIATIC ARTHRITIS AND DERMATITIS

#8
20260069626
2026-03-12

Compositions and Methods to Protect and Enhance Structural and Functional Integrity of the Intestinal Glycocalyx

#9
20260041707
2026-02-12

GASTROINTESTINAL PROTECTANT COMPOSITION

#10
20260034152
2026-02-05

Influx Vitamins and Drinks, with Zinc Ionophoric Influx

#11
20260014193
2026-01-15

COMPOSITIONS AND METHODS FOR DEGENERATIVE DISC REGENERATION

#12
20260014104
2026-01-15

COMPOSITIONS AND METHODS FOR TREATING CYSTITIS

#13
20260009164
2026-01-08

Vascular Constructs

#14
20260007724
2026-01-08

METHODS AND COMPOSITIONS FOR IMPROVING WOUND HEALING

#15
20260007595
2026-01-08

EYE DROP FORMULATIONS CONTAINING CHONDROITIN SULFATE FOR RELIEVING OCULAR PAIN OR DISCOMFORT

#16
20250375463
2025-12-11

NUTRACEUTICAL COMPOSITION FOR COMBATING AGING IN HUMAN AND NON-HUMAN ANIMALS AND BEVERAGES AND/OR FOOD PRODUCTS AND/OR FOOD SUPPLEMENTS CONTAINING THE SAME

#17
20250375462
2025-12-11

NUTRACEUTICAL COMPOSITION FOR COMBATING AGING IN HUMAN AND NON-HUMAN ANIMALS AND BEVERAGES AND/OR FOOD PRODUCTS AND/OR FOOD SUPPLEMENTS CONTAINING THE SAME

#18
20250319192
2025-10-16

EFFICIENT TRANSDERMAL DELIVERY SYSTEM FOR ACIDIC GROUP-CONTAINING BIOMATERIAL

#19
20250281523
2025-09-11

SULFATED GLYCOSAMINOGLYCAN COMPOUNDS, METHODS, AND USES THEREOF

#20
20250249076
2025-08-07

Composition Comprising a Combination of Lactoferrin and a Sulphated Polysaccharide

#21
20250249031
2025-08-07

STORAGE STABLE FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONS

#22
20250249030
2025-08-07

STORAGE STABLE FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONS

#23
20250249029
2025-08-07

TREATMENT OF BONE MARROW PATHOLOGIES WITH POLYSUFATED POLYSACCHARIDES

#24
20250243243
2025-07-31

DISRUPTION OF SONIC HEDGEHOG-SURF4 INTERACTION FOR CANCER TREATMENT

#25
20250228887
2025-07-17

OPHTHALMIC COMPOSITION

#26
20250186338
2025-06-12

Stable Soft Chews, and Methods to Produce Same

#27
20250177435
2025-06-05

MEDICAL USE OF TAFOXIPARIN

#28
20250152618
2025-05-15

ANTIVIRAL SULFATED CHITOSAN DERIVATIVES

#29
20250120999
2025-04-17

SYSTEMS AND METHODS USING SULFATED GLYCOSAMINOGLYCANS (GAGs) AND GAG ANALOGS TO TREAT OR PREVENT MONKEYPOX (MPOX)

#30
20250120998
2025-04-17

REPAIR OF ENDOTHELIAL GLYCOCALYX

#31
20250114427
2025-04-10

COLLAGEN HYDROLYSATE COMPOSITION FOR REDUCING JOINT PAIN AFTER EXERCISE

#32
20250114394
2025-04-10

COMPOSITIONS INCORPORATING SULFATED POLYSACCHARIDES FOR INHIBITING SARS-COV-2

#33
20250108082
2025-04-03

THERAPEUTIC COMBINATIONS FOR INFLAMMATORY CONDITIONS AND DISORDERS

#34
20250090572
2025-03-20

COMPOSITIONS INCORPORATING SULFATED POLYSACCHARIDES FOR INHIBITING SARS-COV-2

#35
20250073258
2025-03-06

Compositions and Methods to Protect and Enhance Structural and Functional Integrity of the Intestinal Glycocalyx

#36
20250017852
2025-01-16

HYDROGEL FORMULATION USED AS VITREOUS SUBSTITUTE AND PRODUCTION METHOD THEREOF

#37
20240424015
2024-12-26

Low-Molecular-Weight HE800 Exopolysaccharide Derivatives with Anti-Cancer Properties and Uses Thereof

#38
20240415874
2024-12-19

METHODS FOR POTENTIATING CANCER TREATMENT USING IONIZING RADIATION

#39
20240398851
2024-12-05

LOW ENDOTOXIN FUCAN COMPOSITIONS, SYSTEMS AND METHODS

#40
20240390412
2024-11-28

USE OF DEXTRAN SULFATE

#41
20240382516
2024-11-21

PHARMACEUTICAL COMPOSITION FOR INCREASING MITOCHONDRIAL ACTIVITY AND/OR IMPROVING ADIPONECTIN PRODUCTION

#42
20240366853
2024-11-07

METHOD FOR MODULATING ENDOTHELIAL GLYCOCALYX STRUCTURE

#43
20240366707
2024-11-07

COMPOSITION FOR THE PREVENTION AND/OR TREATMENT OF GASTRIC AND ESOPHAGEAL DISEASES

#44
20240350532
2024-10-24

Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions

#45
20240350531
2024-10-24

FUCAN AND MODIFIED FUCAN COMPOSITIONS FOR THE TREATMENT OF CONDITIONS RELATED TO CAPSULAR CONTRACTURE AND TO INHIBITING FIBROUS GROWTH AROUND OR ON TRANSPLANTS

#46
20240342208
2024-10-17

Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions

#47
20240327510
2024-10-03

DRUG FOR PREVENTING, ALLEVIATING OR TREATING MUCOSAL ADHESION AND USE THEREOF

#48
20240325474
2024-10-03

BOTANICAL EXTRACTS TO INHIBIT VIRUS INFECTION

#49
20240299442
2024-09-12

ANTIVIRAL AGENTS FOR PREVENTION OR TREATMENT OF PATHOLOGIES CAUSED BY ALPHA- AND/OR BETA-CORONAVIRUSES

#50
20240293443
2024-09-05

HEPARAN SULFATE MIMETICS TO IMPROVE GLUCOSE CLEARANCE

#51
20240287214
2024-08-29

CHLORELLA MANNOGALACTAN OR SULFATED CHLORELLA MANNOGALACTAN COMPOUND AND APPLICATION OF SULFATED CHLORELLA MANNOGALACTAN COMPOUND

#52
20240285675
2024-08-29

USE OF CHONDROITIN SULFATE FOR RELIEVING OCULAR PAIN

#53
20240285674
2024-08-29

USE OF SULFATE GLUCO-GALACTO-OLIGOSACCHARIDE IN PREPARATION OF ANTICOAGULANT AND/OR ANTITHROMBOTIC DRUG

#54
20240252529
2024-08-01

ANTIVIRAL PHARMACEUTICAL COMPOSITION

#55
20240238330
2024-07-18

Methods and Compositions for the Treatment of Pain and/or Inflammation

#56
20240226138
2024-07-11

WATER-ACTIVATED MUCOADHESIVE COMPOSITIONS TO REDUCE INTESTINAL ABSORPTION OF NUTRIENTS

#57
20240207305
2024-06-27

Use of chondroitin sulfate for relieving ocular pain

#58
20240189343
2024-06-13

TREATMENT OF VIRUS INFECTIONS

#59
20240189228
2024-06-13

SUCKABLE AND/OR MELT-IN-MOUTH TABLET BASED ON HYALURONIC ACID AND CHONDROITIN SULPHATE AND SALTS THEREOF

#60
20240189208
2024-06-13

Biocompatible Product Having A Matrix Comprising a Polysaccharide Co-Crosslinked With Chitosan

#61
20240165150
2024-05-23

COMBINATION FOR TREATMENT OF THROMBOINFLAMMATION

#62
20240156858
2024-05-16

Treatment of Bone Marrow Edema (Oedema) With Polysulfated Polysaccharides

#63
20240148781
2024-05-09

RHAMNAN SULFATE-BASED THERAPEUTICS FOR NONALCOHOLIC FATTY LIVER DISEASE AND CIRCADIAN RHYTHM DISORDERS

#64
20240131103
2024-04-25

NOVEL ARTHRITIS EMULGEL COMPOSITION AND ITS PREPARATION PROCESS

#65
20240131053
2024-04-25

WATER-ACTIVATED MUCOADHESIVE COMPOSITIONS TO REDUCE INTESTINAL ABSORPTION OF NUTRIENTS

#66
20240122965
2024-04-18

PH-responsive hydrogel and manufacturing method thereof

#67
20240108648
2024-04-04

Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions

#68
20240108595
2024-04-04

COMPOSITIONS AND METHODS FOR REVERSING AGE-ASSOCIATED DENDRITIC SPINE LOSS

#69
20240099976
2024-03-28

BLENDED FORMULATIONS

#70
20240082296
2024-03-14

TREATMENT OF MUSCLE ATROPHY USING DEXTRAN SULFATE

#71
20240075075
2024-03-07

REPAIR AND/OR RECONSTRUCTION OF INVERTEBRAL DISCS

#72
20240066051
2024-02-29

NASAL SPRAY USING PENTOSAN POLYSULFATE AND MUCOPOLYSACCHARIDE POLYSULFATE FOR COVID-19 PREVENTION AND TREATMENT

#73
20240066050
2024-02-29

TREATMENT OF PAIN WITH POLYSULFATED POLYSACCHARIDES

#74
20240058374
2024-02-22

METHODS FOR PREVENTING CANCER RELAPSE

#75
20240033282
2024-02-01

METHOD FOR IDENTIFYING AND/OR FOR OBTAINING AN ACTIVE SUBSTANCE FOR THE TREATMENT AND THERAPY OF FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS, AND USE OF AN ACTIVE SUBSTANCE FOR THE TREATMENT OF THIS DISEASE

#76
20240026404
2024-01-25

CELLULAR GLYCOSAMINOGLYCAN COMPOSITIONS AND METHODS OF MAKING AND USING

#77
20230390324
2023-12-07

TREATMENT OF FATTY LIVER DISEASES

#78
20230390323
2023-12-07

SPRAYABLE ANTIVIRAL FORMULATION

#79
20230381219
2023-11-30

TREATMENT OF POST-OPERATIVE JOINT PAIN WITH POLYSULFATED POLYSACCHARIDES

#80
20230372235
2023-11-23

Ocular injector and methods for accessing suprachoroidal space of the eye

#81
20230364129
2023-11-16

TOPICAL COMPOSITIONS

#82
20230364128
2023-11-16

TREATMENT OF ALPHAVIRUS-INDUCED INFLAMMATION

#83
20230357670
2023-11-09

POLYSACCHARIDE COMPOSITION AND METHOD FOR REDUCING PROTEIN ADSORPTION

#84
20230355659
2023-11-09

COMPOSITIONS COMPRISING A VEGETABLE CHONDROITIN OR AN ANALOGUE THEREOF AND THE USE THEREOF IN THE TREATMENT OF DISORDERS OF THE MUCOUS MEMBRANE OF THE ORAL, PHARYNGO-LARYNGEAL AND/OR GASTRO-OESOPHAGEAL TRACT

#85
20230355658
2023-11-09

MEDICAL USE OF TAFOXIPARIN

#86
20230346828
2023-11-02

COMPOSITIONS COMPRISING SULFATED POLYSACCHARIDES

#87
20230346827
2023-11-02

TREATMENT OF CORONAVIRUS INFECTIONS

#88
20230329313
2023-10-19

METHODS OF MAKING NON-AQUEOUS CHEWS

#89
20230310492
2023-10-05

SULPHATED XYLANS FOR TREATMENT OR PROPHYLAXIS OF RESPIRATORY DISEASES

#90
20230303644
2023-09-28

TREATMENT OF NERVOUS SYSTEM INJURY AND NEURODEGENERATIVE DISORDERS AND RELATED CONDITIONS

#91
20230285316
2023-09-14

Extended release plastic formulation

#92
20230277580
2023-09-07

CELL PROTECTIVE METHODS AND COMPOSITIONS

#93
20230270802
2023-08-31

ANTIVIRAL PHARMACEUTICAL COMPOSITION

#94
20230263822
2023-08-24

MODULATION OF FACTOR 11 EXPRESSION

#95
20230250199
2023-08-10

LOW MOLECULAR WEIGHT CHONDROITIN SULFATE, COMPOSITION, PREPARATION METHOD AND USE THEREOF

#96
20230241099
2023-08-03

Treatment of bone marrow pathologies with polysulfated polysaccharides

#97
20230241098
2023-08-03

ANTIVIRAL PHARMACEUTICAL COMPOSITION

#98
20230233602
2023-07-27

CONTACT LENS PRODUCT WITH CORNEA REPAIR FUNCTION

#99
20230233598
2023-07-27

Marine Bacterial Exopolysaccharide Derivatives and Uses Thereof in the Treatment of Mucopolysaccharidoses

#100
20230225979
2023-07-20

SOLID ORAL COMPOSITIONS COMPRISING COMPOSITE MONOLITHIC MATRICES FOR CHRONOTROPIC ADMINISTRATION OF ACTIVE INGREDIENTS IN THE GASTROINTESTINAL TRACT

#101
20230210891
2023-07-06

POLYSACCHARIDE COMPOSITIONS AND THERAPEUTIC GELS

#102
20230201250
2023-06-29

Treatment for coronavirus infection and associated cytokine toxicity

#103
20230172970
2023-06-08

Regulated drug delivery via controlled degradable chondroitin sulfate particles

#104
20230172969
2023-06-08

Ophthalmic Composition

#105
20230165917
2023-06-01

Composition and method for treating cancer

#106
20230165890
2023-06-01

HELP APHERESIS FOR THE TREATMENT OF SERIOUSLY ILL COVID-19 PATIENTS

#107
20230152317
2023-05-18

DIAGNOSIS AND TREATMENT OF COVID-19

#108
20230149510
2023-05-18

METHOD FOR ALLEVIATING ARTHRITIS USING EPIDERMAL GROWTH FACTOR

#109
20230149441
2023-05-18

PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ENVELOPED DNA OR RNA VIRUS INDUCED INFECTIONS AND DISORDERS

#110
20230141355
2023-05-11

CXCL8 INHIBITORS FOR USE IN THE TREATMENT OF COVID-19

#111
20230140869
2023-05-11

High-molecular-weight fucans for treating fibrous adhesions and other diseases and conditions

#112
20230137384
2023-05-04

ARTICLE OF MANUFACTURE COMPRISING LOCAL ANESTHETIC, BUFFER, AND GLYCOSAMINOGLYCAN IN SYRINGE WITH IMPROVED STABILITY

#113
20230136817
2023-05-04

TREATMENT OF ACUTE RESPIRATORY DISEASE SYNDROME (ARDS) WITH POLYSULFATED POLYSACCHARIDES

#114
20230132001
2023-04-27

IMMUNITY-BOOSTING AGENT, IMMUNO-THERAPEUTIC ANTI-CANCER AGENT, AND ANTI-CANCER THERAPY ADVERSE EFFECT MITIGATING AGENT CONTAINING ANTHOCYANIN-FUCOIDAN COMPLEX AS ACTIVE INGREDIENT

#115
20230126862
2023-04-27

TREATMENT OF SEPSIS AND HYPERCYTOKINEMIA

#116
20230121154
2023-04-20

COMPOSITIONS AND METHODS FOR DEGENERATIVE DISC REGENERATION

#117
20230120864
2023-04-20

Treatment for coronavirus infection and associated cytokine toxicity

#118
20230120722
2023-04-20

Method for dissolving scars with dextran sulfate

#119
20230111350
2023-04-13

Opthalmic Compositions for Treating Coronaviruses

#120
20230048900
2023-02-16

Extended release plastic formulation

#121
20230043587
2023-02-09

METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DISEASE

#122
20230023285
2023-01-26

PHARMACEUTICAL COMPOSITION FOR USE IN PREVENTING OR STOPPING METASTASES

#123
20230019560
2023-01-19

SYNOVIAL FLUID SUBSTITUTES

#124
20230017195
2023-01-19

COMPOSITIONS AND METHODS OF TREATING VIRAL INFECTIONS

#125
20220370353
2022-11-24

BLENDED FORMULATIONS

#126
20220362324
2022-11-17

MICROBIOME INTERVENTIONS

#127
20220362285
2022-11-17

Water-activated mucoadhesive compositions to reduce intestinal absorption of nutrients

#128
20220362284
2022-11-17

TREATMENT OF BONE MARROW EDEMA (OEDEMA) WITH POLYSULFATED POLYSACCHARIDES

#129
20220354902
2022-11-10

Methods of generating, repairing and/or maintaining connective tissue in vivo

#130
20220347093
2022-11-03

PHARMACEUTICAL COMPOSITION

#131
20220347014
2022-11-03

Ocular injector and methods for accessing suprachoroidal space of the eye

#132
20220331263
2022-10-20

Printed Delivery Device Having Supplements

#133
20220313830
2022-10-06

HEPARIN-PEPTIDE BIOCONJUGATES AND USES THEREOF

#134
20220296634
2022-09-22

Stabilized aqueous composition comprising chondroitin sulfate and hyaluronic acid

#135
20220288286
2022-09-15

ANTITHROMBOTIC COATING COMPOSITION AND ANTITHROMBOTIC COATING METHOD USING SAME

#136
20220280556
2022-09-08

METHOD AND USE OF COMPOSITIONS COMPRISING LIGNOSULFONATE FOR ATTENUATION OF SARS-CoV-2 VIRUS REPLICATION

#137
20220275079
2022-09-01

Clonal Hematopoiesis and Risk of Chronic Liver Disease

#138
20220273698
2022-09-01

MEDICINAL AND/OR PHARMACEUTICAL COMPOSITIONS FOR INTRAVESICAL INSTILLATION, PREPARATION AND USE THEREOF

#139
20220265701
2022-08-25

Liquid composition for use in the treatment of gastroesophageal reflux

#140
20220257640
2022-08-18

NUTRITIONAL FORMULATION FOR CANCER PREVENTION

#141
20220257639
2022-08-18

TREATMENT OF PATIENTS UNDER ANTIPLATELET MEDICATION EXPERIENCING ACUTE BLEEDING COMPLICATIONS DURING/AFTER SURGERY

#142
20220249586
2022-08-11

HEMP EXTRACT AND METHODS OF USE THEREOF

#143
20220249537
2022-08-11

Methods to Stabilize and Reverse Atherosclerotic Lesions by Sulfated Polysaccharides

#144
20220241362
2022-08-04

Multi-efficacy traditional chinese medicine compound composition and application thereof in pharmaceutical preparations

#145
20220202620
2022-06-30

Manifold With Biological Actives For Negative-Pressure Therapy

#146
20220175820
2022-06-09

DEXTRAN SULFATE FOR INFLAMMATORY DERMATOSES

#147
20220152089
2022-05-19

COMPOSITION FOR THE PROTECTION AND REPAIR OF THE BLOOD BRAIN BARRIER

#148
20220143075
2022-05-12

OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING OCULAR SURFACE DISEASE

#149
20220143074
2022-05-12

CHONDROITIN SULFATE POLYSACCHARIDE, AND SEMI-SYNTHETIC PREPARATION METHOD THEREFOR AND USE THEREOF

#150
20220128542
2022-04-28

TREATMENT EFFICIENCY EVALUATION

#151
20220125827
2022-04-28

Application of Sulfated Polysaccharides in Resisting novel Coronavirus

#152
20220080031
2022-03-17

COMPOSITION COMPRISING A COLLAGEN HYDROLYSATE AND A FUCOIDAN

#153
20220079975
2022-03-17

METHOD FOR MITIGATION OF NON-ALCOHOLIC FATTY LIVER DISEASE BY USE OF A COMPOSITION COMPRISING SMALL-MOLECULE FUCOIDAN AND FUCOXANTHIN

#154
20220072038
2022-03-10

Method for modulating endothelial glycocalyx structure

#155
20220072032
2022-03-10

INHIBITORS OF PCSK9 FOR TREATMENT OF LIPOPROTEIN METABOLISM DISORDERS

#156
20220023185
2022-01-27

COMPOSITIONS COMPRISING DERMATAN SULFATE AND CHONDROITIN SULFATE AND USE THEREOF IN COSMETOLOGICAL COMPOSITIONS

#157
20220023184
2022-01-27

Fucoidan hair growth agent

#158
20210401941
2021-12-30

MULTILAYER DRUG DELIVERY COATING FOR CONTACT LENS

#159
20210401873
2021-12-30

Methods for potentiating cancer treatment using ionizing radiation

#160
20210395674
2021-12-23

COMPOSITION FOR INCREASING BIOLOGICAL ACTIVITY OF STEM CELLS USING MIXTURE 4F

#161
20210386834
2021-12-16

COLLAGEN REPLACEMENT/REGENERATION FORMULATION AND USES THEREOF

#162
20210353664
2021-11-18

Compositions and methods comprising growth factors, chondroitin and glucosamine for degenerative disc regeneration

#163
20210353662
2021-11-18

Joint cavity injection preparation and use thereof

#164
20210332162
2021-10-28

DERIVATIVES OF N-DESULFATED GLYCOSAMINOGLYCANS AND USE AS DRUGS

#165
20210330695
2021-10-28

Treatment of pain with polysulfated polysaccharides

#166
20210315922
2021-10-14

Compositions and methods for degenerative disc regeneration

#167
20210315920
2021-10-14

Treatment of glaucoma

#168
20210308228
2021-10-07

METHOD FOR REDUCING THE OCCURRENCE OF THROMBOSIS OR THROMBOEMBOLISM

#169
20210308173
2021-10-07

Pharmaceutical composition comprising cyclodextrin complexes of anethole trithione or derivatives thereof

#170
20210299159
2021-09-30

Low endotoxin fucan compositions, systems, and methods

#171
20210292441
2021-09-23

High-molecular-weight fucans for treating fibrous adhesions and other diseases and conditions

#172
20210290660
2021-09-23

Highly purified and/or modified fucan compositions for the treatment of fibrous adhesions

#173
20210290659
2021-09-23

Highly purified fucans for the treatment of fibrous adhesions

#174
20210290658
2021-09-23

Highly sulfated fucans for the treatment of fibrous adhesions

#175
20210283417
2021-09-16

Methods and compositions for reversing or mitigating skin aging

#176
20210283172
2021-09-16

Article of manufacture comprising local anesthetic, buffer, and glycosaminoglycan in syringe with improved stability

#177
20210275556
2021-09-09

Cannabidiol Combination Compositions

#178
20210269943
2021-09-02

Vascular constructs

#179
20210268004
2021-09-02

COMPOSITION CONTAINING BECLOMETHASONE FOR THE PREVENTION AND THE TREATMENT OF BACTERIAL PROSTATITIS AND VAGINITIS

#180
20210260214
2021-08-26

Compositions for oral administration of pentosan polysulfate in form of nanoparticles with improved intestinal absorption

#181
20210260129
2021-08-26

Cell Expansion Methods and Therapeutic Compositions

#182
20210260098
2021-08-26

Cell protective methods and compositions

#183
20210236538
2021-08-05

Water-activated mucoadhesive compositions to reduce intestinal absorption of nutrients

#184
20210228618
2021-07-29

Methods for preventing a serious health consequence and/or tissue damage after exposure to ionizing radiation and/or chemotherapy

#185
20210220390
2021-07-22

PENTOSAN POLYSULFATE SODIUM FOR THE TREATMENT OF SICKLE CELL DISEASE

#186
20210212940
2021-07-15

APPARATUS AND FORMULATIONS FOR SUPRACHOROIDAL DRUG DELIVERY

#187
20210186883
2021-06-24

NOVEL PENTOSAN POLYSULFATE SODIUM PREPARATION

#188
20210169921
2021-06-10

Modulation of factor 11 expression

#189
20210161950
2021-06-03

Veterinary Supplement for Effecting Bone and Cartilage

#190
20210145733
2021-05-20

Bladder instillation composition with increased storage stability and containing chondroitin sulfate (4.5 mg/ml), hyaluronic acid (16 mg/ml) and phosphate buffer (PH 6.1 to 7.9), for the treatment of cystitis

#191
20210137968
2021-05-13

Bladder instillation composition containing chondroitin sulfate (20 mg/ml), hyaluronic acid (16 mg/ml) and a phosphate buffer (pH 6.1 to 7.9) with increased storage stability for treating cystitis

#192
20210128606
2021-05-06

SULPHATED XYLANS FOR TREATMENT OR PROPHYLAXIS OF RESPIRATORY DISEASES

#193
20210128605
2021-05-06

COMPOSITION FOR PROMOTING SECRETORY IGA SECRETION

#194
20210128604
2021-05-06

Stabilized Glycosaminoglycan Preparations and Related Methods

#195
20210128603
2021-05-06

Combination of a MAPK/ERK pathway inhibitor and a glycosaminoglycan for the treatment of cancer

#196
20210128493
2021-05-06

Pet Food Supplement

#197
20210122796
2021-04-29

Methods of treating spinal cord injury using a chondroitin sulfate proteoglycan (CSPG) reduction peptide (CRP) comprising a cell membrane penetrating domain, a CSPG binding domain, and a lysosome targeting domain

#198
20210113609
2021-04-22

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING PROTEINURIA AND ENDOTHELIAL EROSION

#199
20210113608
2021-04-22

Octasaccharides and uses thereof

#200
20210106610
2021-04-15

Polysaccharides for the treatment of ocular conditions

#201
20210093658
2021-04-01

Methods and compositions for the treatment of pain and/or inflammation

#202
20210069237
2021-03-11

PHARMACEUTICAL COMPOSITIONS COMPRISING HEPARINOIDS AND METHODS FOR PREPARING THEREOF

#203
20210060057
2021-03-04

Use of dextran sulfate

#204
20210054108
2021-02-25

Derivatives of N-desulfated glycosaminoglycans and use as drugs

#205
20210052633
2021-02-25

HYALURONIC ACID SYNTHESIS PROMOTER, METHOD FOR PROMOTING HYALURONIC ACID SYNTHESIS, AND CELL EVALUATION METHOD

#206
20210040218
2021-02-11

DENDRITIC CELL IMMUNORECEPTOR AGONIST

#207
20210038662
2021-02-11

Algal extract comprising sulphated and non-sulphated polyanionic polysaccharides and uses thereof

#208
20210032376
2021-02-04

Glycosaminoglycan derivative and preparation method therefor and use thereof

#209
20210023124
2021-01-28

Treatment of alphavirus-induced inflammation

#210
20210023007
2021-01-28

BLENDED FORMULATIONS

#211
20210018518
2021-01-21

METHOD OF DIAGNOSIS, PROGNOSIS OR TREATMENT OF NEURODEGENERATIVE DISEASES

#212
20210017301
2021-01-21

F-fucoidan, desulfated F-fucoidan, and its processed derivatives in terms of desulfated oligo-fucose as inhibitors of gastrointestinal infection

#213
20210015849
2021-01-21

Treatment of bone marrow edema (OEDEMA) with polysulfated polysaccharides

#214
20210007989
2021-01-14

Multiphasic compositions

#215
20210000862
2021-01-07

Treatment of post-operative joint pain with polysulfated polysaccharides

#216
20200407468
2020-12-31

Water-soluble polysaccharide derivatives, process for their preparation, and their uses

#217
20200405751
2020-12-31

OPHTHALMIC PRODUCT WITH CORNEA REPAIR FUNCTION

#218
20200405745
2020-12-31

LIQUID COMPOSITION FOR USE IN THE TREATMENT OF THE MUCOSA OF THE ORO-PHARYNGO-LARYNGO-ESOPHAGEAL TRACT

#219
20200390692
2020-12-17

APPARATUS AND FORMULATIONS FOR SUPRACHOROIDAL DRUG DELIVERY

#220
20200384012
2020-12-10

Pentosan polysulfate and medicine containing pentosan polysulfate

#221
20200376072
2020-12-03

Methods and compositions for the prevention and treatment of disease

#222
20200376066
2020-12-03

IMMUNITY-BOOSTING AGENT, IMMUNO-THERAPEUTIC ANTI-CANCER AGENT, AND ANTI-CANCER THERAPY ADVERSE EFFECT MITIGATING AGENT CONTAINING ANTHOCYANIN-FUCOIDAN COMPLEX AS ACTIVE INGREDIENT

#223
20200360422
2020-11-19

Compositions comprising sulfated polysaccharides

#224
20200345760
2020-11-05

STABILIZED AQUEOUS COMPOSITION COMPRISING CHONDROITIN SULFATE AND HYALURONIC ACID

#225
20200338115
2020-10-29

Pharmaceutical composition for prevention of recurrent urinary tract infection

#226
20200338114
2020-10-29

PHARMACEUTICAL COMPOSITIONS AND METHODS RELATING TO INHIBITING FIBROUS ADHESIONS OR INFLAMMATORY DISEASE USING LOW SULPHATE FUCANS

#227
20200337996
2020-10-29

SUCKABLE AND/OR MELT-IN-MOUTH TABLET BASED ON HYALURONIC ACID AND CHONDROITIN SULPHATE AND SALTS THEREOF

#228
20200337995
2020-10-29

SUCKABLE AND/OR MELT-IN-MOUTH TABLET BASED ON HYALURONIC ACID AND CHONDROITIN SULPHATE AND SALTS THEREOF FOR USE IN THE TREATMENT OF A SUBPOPULATION OF GERD PATIENTS

#229
20200332088
2020-10-22

Cellular glycosaminoglycan compositions and methods of making and using

#230
20200330783
2020-10-22

Methods and compositions for treatment of pigmented lesions

#231
20200330504
2020-10-22

INHIBITORS OF PCSK9 FOR TREATMENT OF LIPOPROTEIN METABOLISM DISORDERS

#232
20200316175
2020-10-08

Nutritional composition for treating or preventing impaired mobility

#233
20200289548
2020-09-17

FUCOIDAN HAIR GROWTH AGENT

#234
20200289455
2020-09-17

Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease

#235
20200262939
2020-08-20

Photo-coupled synergistically crosslinked hydrogel material and its composition, preparation method, use, product, and preparation kit

#236
20200261493
2020-08-20

Mixture of fucosylated chondroitin sulfate oligosaccharides and method for rapidly producing the same

#237
20200246374
2020-08-06

Treatment of bone marrow pathologies with polysufated polysaccharides

#238
20200237805
2020-07-30

Compound composition with function of promoting bone and joint health and application thereof

#239
20200237804
2020-07-30

METHODS AND COMPOSITIONS FOR TREATING CHRONIC RHINOSINUSITIS

#240
20200230169
2020-07-23

Compositions and methods for preventing/treating metabolic syndrome

#241
20200229407
2020-07-23

PRODUCTS AND METHODS ASSOCIATED WITH MULTIPLE SCLEROSIS AS A TRANSMISSIBLE PROTEIN MISFOLDING DISORDER

#242
20200216577
2020-07-09

Derivatives of N-desulfated glycosaminoglycans and use as drugs

#243
20200215099
2020-07-09

NON-ANTICOAGULANT SULFATED OR SULFONATED POLYSACCHARIDES

#244
20200171075
2020-06-04

Compositions comprising sulfated polysaccharides

#245
20200163364
2020-05-28

SHREDDED-MEAT-SHAPED PET FOOD AND PREPARATION METHOD THEREOF

#246
20200131237
2020-04-30

Methods of treating spinal cord injury using a chondroitin sulfate proteoglycan (CSPG) reduction peptide (CRP) comprising a cell membrane penetrating domain, a CSPG binding domain, and a lysosome targeting domain

#247
20200129591
2020-04-30

Composition having tissue-repairing activity, and use therefor

#248
20200115472
2020-04-16

PHARMACEUTICAL COMPOUNDS COMPRISING MODIFIED FUCANS AND METHODS RELATING THERETO

#249
20200101118
2020-04-02

METHODS OF GENERATING, REPAIRING AND/OR MAINTAINING CONNECTIVE TISSUE IN VIVO

#250
20200093852
2020-03-26

Methods of Treating Ocular Disorders

#251
20200085855
2020-03-19

DEVICE AND METHOD TO TREAT OR PREVENT JOINT DEGENERATION

#252
20200078469
2020-03-12

HEPARIN-PEPTIDE BIOCONJUGATES AND USES THEREOF

#253
20200062867
2020-02-27

Pentosan polysulfate, pharmaceutical composition, and anticoagulant

#254
20200061101
2020-02-27

Compositions prepared from poultry and methods of their use

#255
20200061100
2020-02-27

Methods for treating respiratory conditions using ionic aqueous polysaccharide compositions

#256
20200054668
2020-02-20

SULPHATED XYLANS FOR TREATMENT OR PROPHYLAXIS OF RESPIRATORY DISEASES

#257
20200046754
2020-02-13

Water-activated mucoadhesive compositions to reduce intestinal absorption of nutrients

#258
20200038433
2020-02-06

AQUEOUS COMPOSITION DERIVED FROM SEAWATER AND SEAWEED

#259
20200023001
2020-01-23

GlycoFix (Structurally And Functionally Repaired Endothelial Glycocalyx)

#260
20200010573
2020-01-09

Medicines for topic use based on sulfated hyaluronic acid as activating or inhibiting agent of the cytokine activity

#261
20200000839
2020-01-02

Modulation of Factor 11 expression

#262
20190374566
2019-12-12

COMPOSITION FOR PREVENTING AND TREATING ARTHRITIS, INCLUDING DNA FRAGMENT MIXTURE AND MATRIX METALLOPROTEINASE PRODUCTION INHIBITOR

#263
20190366113
2019-12-05

Combination of an oxidant and a photoactivator for the wounds

#264
20190358209
2019-11-28

DRUG COMPOSITIONS

#265
20190350968
2019-11-21

Compositions and methods for degenerative disc regeneration

#266
20190343870
2019-11-14

Application of alginic acid sulfate in preparation of drugs and health care products for preventing and treating diseases caused by human papilloma viruses

#267
20190321391
2019-10-24

NOVEL INTERSTITIAL THERAPY FOR IMMEDIATE SYMPTOM RELIEF AND CHRONIC THERAPY IN INTERSTITIAL CYSTITIS

#268
20190298757
2019-10-03

EDIBLE SEMI-SOLID COMPOSITION FOR USE IN PATIENTS UNDERGOING ENDOSCOPY INCLUDING COLONOSCOPY

#269
20190282607
2019-09-19

Chondroitin sulfate derivative and agent for treating bladder diseases

#270
20190282606
2019-09-19

Inhibitors of ADAMTS4 or ADAMTS5 for use in preventing or treating cardiac remodeling and chronic heart failure

#271
20190263940
2019-08-29

Process for the production of high-purity sulfated HA

#272
20190262388
2019-08-29

Liquid composition for use in the treatment of gastroesophageal reflux

#273
20190255097
2019-08-22

TREATMENT OF ALPHAVIRUS-INDUCED INFLAMMATION

#274
20190247422
2019-08-15

COMPOSITION FOR PROMOTING SECRETORY IGA SECRETION

#275
20190240335
2019-08-08

Biocompatible Hydrogel Compositions

#276
20190231810
2019-08-01

Low polydispersity, low molecular weight biotechnological chondroitin sulfate with anti-inflammatory and antiarthritis activity and use thereof in the prevention of osteoarthritis

#277
20190224229
2019-07-25

KEFIRAN FOR USE IN REGENERATIVE MEDICINE AND/OR TISSUE ENGINEERING

#278
20190216844
2019-07-18

Methods to stabilize and reverse atherosclerotic lesions by sulfated polysaccharides

#279
20190209606
2019-07-11

In situ gelling compositions for the treatment or prevention of inflammation and tissue damage

#280
20190192553
2019-06-27

Compositions for the skin

#281
20190183922
2019-06-20

NOVEL ACTIVE IMMUNOMODULATORY AGENT AND COMPOSITION CONTAINING SAME

#282
20190183921
2019-06-20

Compositions and methods to affect skin irritation

#283
20190175680
2019-06-13

COMPOSITIONS COMPRISING NANOPARTICLES DERIVED FROM WHOLE FRUIT

#284
20190175640
2019-06-13

Compositions comprising sulfated polysaccharides and uses thereof

#285
20190169317
2019-06-06

Unsaturated derivatives of polysaccharides, method of preparation thereof and use thereof

#286
20190167715
2019-06-06

Compositions and methods for treating and preventing proteinuria and endothelial erosion

#287
20190151351
2019-05-23

REGULATORS OF ANAPLASTIC LYMPHOMA KINASE AND USES THEREOF

#288
20190143137
2019-05-16

Methods and compositions for treatment of pigmented lesions

#289
20190142960
2019-05-16

Fucoidan nanogels and methods of their use and manufacture

#290
20190127884
2019-05-02

Vascular constructs

#291
20190125782
2019-05-02

NON-ANTICOAGULANT SULFATED OR SULFONATED POLYSACCHARIDES

#292
20190125781
2019-05-02

Compositions and methods to affect skin irritation

#293
20190125664
2019-05-02

TABLET TO BE SUCKED AND/OR DISSOLVED IN THE MOUTH BASED ON HYALURONIC ACID AND CHONDROITIN SULPHATE AND THEIR SALTS

#294
20190008924
2019-01-10

Methods for generating immunotolerant responses

#295
20190008891
2019-01-10

STABILIZED AQUEOUS COMPOSITION COMPRISING CHONDROITIN SULFATE AND HYALURONIC ACID

#296
20180360916
2018-12-20

Isolation and Identification of Glycosaminoglycans

#297
20180344874
2018-12-06

Cysteine Peptide-Containing Health Drink

#298
20180333358
2018-11-22

DRUG COMPOSITIONS

#299
20180326090
2018-11-15

Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use

#300
20180318336
2018-11-08

PENTOSAN POLYSULFATE SODIUM FOR THE TREATMENT OF SICKLE CELL DISEASE